Defining renal risk

Current Opinion in Nephrology and Hypertension

Volumn 16, Issue 6, 2007, Pages 554-556

  Taal, Maarten W ^a,c   Brenner, Barry M ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DERBY CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE PREDISPOSITION; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

HUMANS; KIDNEY DISEASES; MODELS, STATISTICAL; RISK FACTORS; TERMINOLOGY AS TOPIC;

EID: 37349096304     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3282f09f26     Document Type: Editorial

References (23)

1. Kidney Disease Outcomes Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
2. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145:247-254.
3. Centers for Disease Control and Prevention. Prevalence of chronic kidney disease and associated risk factors: United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007; 56:161-165.
4. Boulware LE, Jaar BG, Tarver-Carr ME, et al. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 2003; 290:3101-3114.
5. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int 2006; 70:1694-1705.
6. Iseki K, Iseki C, Ikemiya Y, et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49:800-805.
7. Verhave JC, Gansevoort RT, Hillege HL, et al. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int Suppl 2004; S18-S21.
8. Retnakaran R, Cull CA, Thorne KI, et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006; 55:1832-1839.
9. Keane WF, Zhang Z, Lyle PA, et al. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL Study. Clin J Am Soc Nephrol 2006; 1:761-767.
10. Atkins RC, Briganti EM, Lewis JB, et al. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 2005; 45:281-287.
11. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51:1908-1919.
12. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, nondiabetic nephropathy. Lancet 1997; 349:1857-1863.
13. Lea J, Greene T, Hebert L, et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Int Med 2005; 165:947-953.
14. Ruggenenti P, Perna A, Remuzzi G. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int 2003; 63: 2254-2261.
15. Jafar TH, Stark PC, Schmid CH, et al. Proteinuria as a modifiable risk factor for the progression of nondiabetic renal disease. Kidney Int 2001; 60:1131-1140.
16. Hou FF, Xie D, Zhang X, et al. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency. J Am Soc Nephrol 2007; 18:1889-1898.
17. Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006; 17:2974-2984.
18. Zandi-Nejad K, Eddy AA, Glassock RJ, et al. Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int Suppl 2004; 92:S76-S89.
19. Kent DM, Jafar TH, Hayward RA, et al. Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol 2007; 18:1959-1965.
20. UK Consensus Conference on early stage CKD. UK consensus statement on the management of early CKD; 2007. http://www.renal.org/CKDguide/consensus.html. [Accessed 3 August 2007]
21. Wakai K, Kawamura T, Endoh M, et al. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant 2006; 21:2800-2808.
22. Dimitrov BD, Perna A, Ruggenenti P, et al. Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual level. Kidney Int 2003; 63:1924-1933.
23. Kannel WB, Larson M. Long-term epidemiologic prediction of coronary disease: the Framingham experience. Cardiology 1993; 82:137-152.